Browsing by Author "Mill, Jonathan"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET
    (Springer Nature, 2024-09-20) Nho, Kwangsik; Risacher, Shannon L.; Apostolova, Liana G.; Bice, Paula J.; Brosch, Jared R.; Deardorff, Rachael; Faber, Kelley; Farlow, Martin R.; Foroud, Tatiana; Gao, Sujuan; Rosewood, Thea; Kim, Jun Pyo; Nudelman, Kelly; Yu, Meichen; Aisen, Paul; Sperling, Reisa; Hooli, Basavaraj; Shcherbinin, Sergey; Svaldi, Diana; Jack, Clifford R., Jr.; Jagust, William J.; Landau, Susan; Vasanthakumar, Aparna; Waring, Jeffrey F.; Doré, Vincent; Laws, Simon M.; Masters, Colin L.; Porter, Tenielle; Rowe, Christopher C.; Villemagne, Victor L.; Dumitrescu, Logan; Hohman, Timothy J.; Libby, Julia B.; Mormino, Elizabeth; Buckley, Rachel F.; Johnson, Keith; Yang, Hyun-Sik; Petersen, Ronald C.; Ramanan, Vijay K.; Ertekin-Taner, Nilüfer; Vemuri, Prashanthi; Cohen, Ann D.; Fan, Kang-Hsien; Kamboh, M. Ilyas; Lopez, Oscar L.; Bennett, David A.; Ali, Muhammad; Benzinger, Tammie; Cruchaga, Carlos; Hobbs, Diana; De Jager, Philip L.; Fujita, Masashi; Jadhav, Vaishnavi; Lamb, Bruce T.; Tsai, Andy P.; Castanho, Isabel; Mill, Jonathan; Weiner, Michael W.; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Department of Defense Alzheimer’s Disease Neuroimaging Initiative (DoD-ADNI); Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN); Australian Imaging, Biomarker & Lifestyle Study (AIBL); Saykin, Andrew J.; Radiology and Imaging Sciences, School of Medicine
    Determining the genetic architecture of Alzheimer's disease pathologies can enhance mechanistic understanding and inform precision medicine strategies. Here, we perform a genome-wide association study of cortical tau quantified by positron emission tomography in 3046 participants from 12 independent studies. The CYP1B1-RMDN2 locus is associated with tau deposition. The most significant signal is at rs2113389, explaining 4.3% of the variation in cortical tau, while APOE4 rs429358 accounts for 3.6%. rs2113389 is associated with higher tau and faster cognitive decline. Additive effects, but no interactions, are observed between rs2113389 and diagnosis, APOE4, and amyloid beta positivity. CYP1B1 expression is upregulated in AD. rs2113389 is associated with higher CYP1B1 expression and methylation levels. Mouse model studies provide additional functional evidence for a relationship between CYP1B1 and tau deposition but not amyloid beta. These results provide insight into the genetic basis of cerebral tau deposition and support novel pathways for therapeutic development in AD.
  • Thumbnail Image
    Item
    Uncovering the genetic architecture of broad antisocial behavior through a genome-wide association study meta-analysis
    (Springer Nature, 2022) Tielbeek, Jorim J.; Uffelmann, Emil; Williams, Benjamin S.; Colodro-Conde, Lucía; Gagnon, Éloi; Mallard, Travis T.; Levitt, Brandt E.; Jansen, Philip R.; Johansson, Ada; Sallis, Hannah M.; Pistis, Giorgio; Saunders, Gretchen R. B.; Allegrini, Andrea G.; Rimfeld, Kaili; Konte, Bettina; Klein, Marieke; Hartmann, Annette M.; Salvatore, Jessica E.; Nolte, Ilja M.; Demontis, Ditte; Malmberg, Anni L. K.; Burt, S. Alexandra; Savage, Jeanne E.; Sugden, Karen; Poulton, Richie; Mullan Harris, Kathleen; Vrieze, Scott; McGue, Matt; Iacono, William G.; Roth Mota, Nina; Mill, Jonathan; Viana, Joana F.; Mitchell, Brittany L.; Morosoli, Jose J.; Andlauer, Till F. M.; Ouellet-Morin, Isabelle; Tremblay, Richard E.; Côté, Sylvana M.; Gouin, Jean-Philippe; Brendgen, Mara R.; Dionne, Ginette; Vitaro, Frank; Lupton, Michelle K.; Martin, Nicholas G.; COGA Consortium; Spit for Science Working Group; Castelao, Enrique; Räikkönen, Katri; Eriksson, Johan G.; Lahti, Jari; Hartman, Catharina A.; Oldehinkel, Albertine J.; Snieder, Harold; Liu, Hexuan; Preisig, Martin; Whipp, Alyce; Vuoksimaa, Eero; Lu, Yi; Jern, Patrick; Rujescu, Dan; Giegling, Ina; Palviainen, Teemu; Kaprio, Jaakko; Harden, Kathryn Paige; Munafò, Marcus R.; Morneau-Vaillancourt, Geneviève; Plomin, Robert; Viding, Essi; Boutwell, Brian B.; Aliev, Fazil; Dick, Danielle M.; Popma, Arne; Faraone, Stephen V.; Børglum, Anders D.; Medland, Sarah E.; Franke, Barbara; Boivin, Michel; Pingault, Jean-Baptiste; Glennon, Jeffrey C.; Barnes, J. C.; Fisher, Simon E.; Moffitt, Terrie E.; Caspi, Avshalom; Polderman, Tinca J. C.; Posthuma, Danielle; Medical and Molecular Genetics, School of Medicine
    Despite the substantial heritability of antisocial behavior (ASB), specific genetic variants robustly associated with the trait have not been identified. The present study by the Broad Antisocial Behavior Consortium (BroadABC) meta-analyzed data from 28 discovery samples (N = 85,359) and five independent replication samples (N = 8058) with genotypic data and broad measures of ASB. We identified the first significant genetic associations with broad ASB, involving common intronic variants in the forkhead box protein P2 (FOXP2) gene (lead SNP rs12536335, p = 6.32 × 10-10). Furthermore, we observed intronic variation in Foxp2 and one of its targets (Cntnap2) distinguishing a mouse model of pathological aggression (BALB/cJ strain) from controls (BALB/cByJ strain). Polygenic risk score (PRS) analyses in independent samples revealed that the genetic risk for ASB was associated with several antisocial outcomes across the lifespan, including diagnosis of conduct disorder, official criminal convictions, and trajectories of antisocial development. We found substantial genetic correlations of ASB with mental health (depression rg = 0.63, insomnia rg = 0.47), physical health (overweight rg = 0.19, waist-to-hip ratio rg = 0.32), smoking (rg = 0.54), cognitive ability (intelligence rg = -0.40), educational attainment (years of schooling rg = -0.46) and reproductive traits (age at first birth rg = -0.58, father's age at death rg = -0.54). Our findings provide a starting point toward identifying critical biosocial risk mechanisms for the development of ASB.